BIOACTIVE AGENTS FROM DRYLAND BIODIVERSITY OF LATIN AMER
Project Number3U01TW000316-10S2
Contact PI/Project LeaderTIMMERMANN, BARBARA
Awardee OrganizationUNIVERSITY OF ARIZONA
Description
Abstract Text
DESCRIPTION: (Applicant's Description)
The long term objectives of the Latin American ICBG are to discover and
develop biologically active agents from natural sources to promote sustained
economic growth while conserving natural resources from which these products
are derived. This program seeks to identify new therapeutic agents that are
candidates or can serve as leads in the treatment of infectious diseases,
cardiovascular and central nervous system disorders, cancer and
inflammation, women's health as well as illnesses prevalent in developing
countries. This ICBG project also searches for leads for agricultural crop
protection (herbicides, fungicides and insecticides) and veterinary
medicine. Studies will include plants and microbes mainly from dryland
ecosystems in Argentina, Chile and Mexico. The specific aims are to: 1)
identify plants and their populations that are utilized in local health
practices or show some mechanism of resistance to natural predators; 2)
isolate and identify unusual populations of microbes from selected plant
communities; 3) evaluate the biological activities of these plants and
microbes; 4) isolate and chemically identify the active compounds in these
natural resources and promote their use for human, animal or agricultural
benefit; 5) return benefits (derived from these resources) to the local
communities in order to promote conservation of the plants and their habitat
as well as improve the life of the communities; 6) develop a plant catalog
database and its representative Web site; 7) publish a newsletter in print
and online; 8) foster academic advancement and capacity building in each
host country; 9) work on ecological restoration projects and establishment
of regional botanical gardens as part of conservation activities; 10) aid
host governments towards legislation for conservation and facilitation of
access to biological resources, and 11) organize periodical workshops for
the general public, teachers and the academic community. The successful
discovery of rare, novel therapeutic agents and agrochemicals depends upon
the rapid evaluation of large numbers of chemically diverse compounds in
targeted, high volume detection systems. This ICBG has the capabilities to
reach the proposed objectives through the application of the latest
developments in spectroscopic and spectrometric methods as well as in
robotic, micro-instrumentation and computerization.
John E. Fogarty International Center for Advanced Study in the Health Sciences
CFDA Code
989
DUNS Number
806345617
UEI
ED44Y3W6P7B9
Project Start Date
30-September-1993
Project End Date
29-September-2004
Budget Start Date
30-September-2002
Budget End Date
29-September-2004
Project Funding Information for 2003
Total Funding
$40,000
Direct Costs
$40,000
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2003
John E. Fogarty International Center for Advanced Study in the Health Sciences
$40,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3U01TW000316-10S2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3U01TW000316-10S2
Patents
No Patents information available for 3U01TW000316-10S2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3U01TW000316-10S2
Clinical Studies
No Clinical Studies information available for 3U01TW000316-10S2
News and More
Related News Releases
No news release information available for 3U01TW000316-10S2
History
No Historical information available for 3U01TW000316-10S2
Similar Projects
No Similar Projects information available for 3U01TW000316-10S2